WO2007149486A3 - Methods and materials for observing apoptosis by detecting fragments of clathrin-pathway components - Google Patents

Methods and materials for observing apoptosis by detecting fragments of clathrin-pathway components Download PDF

Info

Publication number
WO2007149486A3
WO2007149486A3 PCT/US2007/014382 US2007014382W WO2007149486A3 WO 2007149486 A3 WO2007149486 A3 WO 2007149486A3 US 2007014382 W US2007014382 W US 2007014382W WO 2007149486 A3 WO2007149486 A3 WO 2007149486A3
Authority
WO
WIPO (PCT)
Prior art keywords
materials
clathrin
methods
apoptosis
pathway components
Prior art date
Application number
PCT/US2007/014382
Other languages
French (fr)
Other versions
WO2007149486A2 (en
Inventor
Cary D Austin
David A Lawrence
Avi Ashkenazi
Original Assignee
Genentech Inc
Cary D Austin
David A Lawrence
Avi Ashkenazi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP2009516559A priority Critical patent/JP5222845B2/en
Application filed by Genentech Inc, Cary D Austin, David A Lawrence, Avi Ashkenazi filed Critical Genentech Inc
Priority to AU2007261405A priority patent/AU2007261405B2/en
Priority to US12/308,542 priority patent/US8198033B2/en
Priority to NZ574009A priority patent/NZ574009A/en
Priority to CN200780030709.4A priority patent/CN101535805B/en
Priority to MX2008016170A priority patent/MX2008016170A/en
Priority to CA2655460A priority patent/CA2655460C/en
Priority to KR1020097001055A priority patent/KR101433971B1/en
Priority to BRPI0712629A priority patent/BRPI0712629C1/en
Priority to EP07809716.9A priority patent/EP2044434B1/en
Publication of WO2007149486A2 publication Critical patent/WO2007149486A2/en
Publication of WO2007149486A3 publication Critical patent/WO2007149486A3/en
Priority to IL195973A priority patent/IL195973A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/686—Anti-idiotype
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2510/00—Detection of programmed cell death, i.e. apoptosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The invention provides methods and materials for observing protein fragments generated during apoptosis in order to observe this process in mammalian cells. Embodiments of the invention can be used for example to observe apoptosis in order to examine the sensitivity of a mammalian cancer cell to apoptosis inducing agents.
PCT/US2007/014382 2006-06-20 2007-06-20 Methods and materials for observing apoptosis by detecting fragments of clathrin-pathway components WO2007149486A2 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
MX2008016170A MX2008016170A (en) 2006-06-20 2007-06-20 Methods and materials for observing apoptosis by detecting fragments of clathrin-pathway components.
AU2007261405A AU2007261405B2 (en) 2006-06-20 2007-06-20 Methods and materials for observing apoptosis by detecting fragments of clathrin-pathway components
US12/308,542 US8198033B2 (en) 2006-06-20 2007-06-20 Methods and materials for observing apoptosis
NZ574009A NZ574009A (en) 2006-06-20 2007-06-20 Methods and materials for observing apoptosis by detecting fragments of clathrin-pathway components
CN200780030709.4A CN101535805B (en) 2006-06-20 2007-06-20 Methods and materials for observing apoptosis by detecting fragments of clathrin-pathway components
JP2009516559A JP5222845B2 (en) 2006-06-20 2007-06-20 Methods and materials for observing apoptosis
CA2655460A CA2655460C (en) 2006-06-20 2007-06-20 Methods and materials for observing apoptosis
EP07809716.9A EP2044434B1 (en) 2006-06-20 2007-06-20 Methods and materials for observing apoptosis by detecting fragments of clathrin-pathway components
BRPI0712629A BRPI0712629C1 (en) 2006-06-20 2007-06-20 method for detecting apoptosis and method for identifying a human cancer cell
KR1020097001055A KR101433971B1 (en) 2006-06-20 2007-06-20 Methods and materials for observing apoptosis by detecting fragments of clathrin-pathway components
IL195973A IL195973A (en) 2006-06-20 2008-12-16 Methods and materials for observing apoptosis

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81495506P 2006-06-20 2006-06-20
US60/814,955 2006-06-20

Publications (2)

Publication Number Publication Date
WO2007149486A2 WO2007149486A2 (en) 2007-12-27
WO2007149486A3 true WO2007149486A3 (en) 2008-03-20

Family

ID=38834096

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/014382 WO2007149486A2 (en) 2006-06-20 2007-06-20 Methods and materials for observing apoptosis by detecting fragments of clathrin-pathway components

Country Status (14)

Country Link
US (1) US8198033B2 (en)
EP (1) EP2044434B1 (en)
JP (1) JP5222845B2 (en)
KR (1) KR101433971B1 (en)
CN (1) CN101535805B (en)
AU (1) AU2007261405B2 (en)
BR (1) BRPI0712629C1 (en)
CA (1) CA2655460C (en)
IL (1) IL195973A (en)
MX (1) MX2008016170A (en)
NZ (1) NZ574009A (en)
RU (1) RU2450273C2 (en)
WO (1) WO2007149486A2 (en)
ZA (1) ZA200900043B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5133842B2 (en) * 2008-10-14 2013-01-30 国立大学法人 千葉大学 Method for discriminating between cancerous part and non-cancerous part of patient suspected of cancer or tissue derived from cancer patient, and discrimination reagent used therefor
RU2508542C1 (en) * 2012-07-16 2014-02-27 Полина Михайловна Шварцбурд Rapid method for determining risk of cell malignancy
US11299528B2 (en) 2014-03-11 2022-04-12 D&D Pharmatech Inc. Long acting TRAIL receptor agonists for treatment of autoimmune diseases
US11007251B2 (en) 2015-12-17 2021-05-18 The Johns Hopkins University Ameliorating systemic sclerosis with death receptor agonists
WO2017177148A1 (en) 2016-04-07 2017-10-12 The Johns Hopkins University Compositions and methods for treating pancreatitis and pain with death receptor agonists
GB201615842D0 (en) * 2016-09-16 2016-11-02 Ucl Business Plc Cell death biomarker

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000017648A1 (en) * 1998-09-24 2000-03-30 Promega Corporation Apoptosis marker antibodies and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5935801A (en) * 1996-03-29 1999-08-10 Dana-Farber Cancer Institute Monoclonal antibody that detects apoptotic antigen
CA2324995A1 (en) * 1998-04-17 1999-10-28 University Of Vermont And State Agricultural College Methods and products related to metabolic interactions in disease
US20040029189A1 (en) * 2000-12-22 2004-02-12 Izumi Sugo Method of measuring cell death of target cells
US6797677B2 (en) 2002-05-30 2004-09-28 Afton Chemical Corporation Antioxidant combination for oxidation and deposit control in lubricants containing molybdenum and alkylated phenothiazine
AU2004256425A1 (en) * 2003-06-09 2005-01-20 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000017648A1 (en) * 1998-09-24 2000-03-30 Promega Corporation Apoptosis marker antibodies and methods of use

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
AUSTIN CARY D ET AL: "Death-receptor activation halts clathrin-dependent endocytosis.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 5 JUL 2006, vol. 103, no. 27, 5 July 2006 (2006-07-05), pages 10283 - 10288, XP002464806, ISSN: 0027-8424 *
ENARI MASATO ET AL: "Requirement of clathrin heavy chain for p53-mediated transcription", GENES & DEVELOPMENT, vol. 20, no. 9, May 2006 (2006-05-01), pages 1087 - 1099, XP002464807, ISSN: 0890-9369 *
HANSEN B ET AL: "Stabilin-1 and stabilin-2 are both directed into the early endocytic pathway in hepatic sinusoidal endothelium via interactions with clathrin/AP-2, independent of ligand binding", EXPERIMENTAL CELL RESEARCH, SAN DIEGO, CA, US, vol. 303, no. 1, 1 February 2005 (2005-02-01), pages 160 - 173, XP004657342, ISSN: 0014-4827 *
WETTEY FRANK R ET AL: "Controlled elimination of clathrin heavy-chain expression in DT40 lymphocytes.", SCIENCE (NEW YORK, N.Y.) 30 AUG 2002, vol. 297, no. 5586, 30 August 2002 (2002-08-30), pages 1521 - 1525, XP002464805, ISSN: 1095-9203 *

Also Published As

Publication number Publication date
WO2007149486A2 (en) 2007-12-27
CN101535805A (en) 2009-09-16
US8198033B2 (en) 2012-06-12
KR101433971B1 (en) 2014-08-25
IL195973A0 (en) 2009-09-01
EP2044434A2 (en) 2009-04-08
US20110244473A1 (en) 2011-10-06
MX2008016170A (en) 2009-02-03
EP2044434B1 (en) 2015-11-18
KR20090024795A (en) 2009-03-09
BRPI0712629C1 (en) 2021-07-27
NZ574009A (en) 2012-01-12
AU2007261405B2 (en) 2013-02-14
AU2007261405A1 (en) 2007-12-27
JP2009541741A (en) 2009-11-26
JP5222845B2 (en) 2013-06-26
IL195973A (en) 2011-05-31
BRPI0712629A2 (en) 2012-10-23
BRPI0712629B8 (en) 2018-09-25
BRPI0712629B1 (en) 2018-07-17
CA2655460A1 (en) 2007-12-27
ZA200900043B (en) 2010-03-31
RU2009101512A (en) 2010-07-27
CN101535805B (en) 2014-02-12
CA2655460C (en) 2014-05-20
RU2450273C2 (en) 2012-05-10

Similar Documents

Publication Publication Date Title
SG170065A1 (en) Human embryonic stem cell methods and podxl expression
IL188874A0 (en) APOPTOSIS SENSIVITY TO AP02L/TRAIL BY TESTING FOR GalNac -T14 EXPRESSION IN CELLS/TISSUES
WO2007149486A3 (en) Methods and materials for observing apoptosis by detecting fragments of clathrin-pathway components
AU2013207599A1 (en) Process for determining one or more analytes in samples of biological origin having complex composition, and use thereof
WO2010039627A3 (en) Biodetection articles
ATE519757T1 (en) 3 HYDROXYFLAVONE DERIVATIVES FOR DETECTION AND QUANTIFICATION OF CELL APOPTOSIS
IL187064A0 (en) System for rapid analysis of microbiological materials in liquid samples
AU2007255110A8 (en) Circulating tumor cell assay
HK1129340A1 (en) Vials and apparatus for obtaining an aliquot of a sample
EP1981983A4 (en) Method and composition for rapid viability testing of cells
EP1966731A4 (en) Method for ascertaining interferants in small liquid samples in an automated clinical analyzer
MX2010009766A (en) Protease assay.
EP3851856A3 (en) Method, array and use thereof
WO2009007846A3 (en) Methods for modifying, isolating, detecting, visualizing, and quantifying citrullinated and/or homocitrullinated peptides, polypeptides and proteins
MX2012000322A (en) A method of analyzing cellulose decay in cellulosic material hydrolysis.
WO2007140352A3 (en) Plasma membrane and secreted cancer biomarkers
MY161825A (en) Methods for counting cells
IN2012DN00852A (en)
PT2294176T (en) Sample chamber adapter, in particular for the cryoconservation of biological samples
MX2009001070A (en) Use of melanoma inhibitory activity (mia) protein as an early indicator for therapeutic response in melanoma.
EP2357251A4 (en) Method and kit for detecting biological signal of three-dimensional cell culture material
WO2009023331A3 (en) Antibodies and improved test sample handling methods for use in assays for myeloperoxidase
WO2010033991A3 (en) Detection of human somatic cell reprogramming
WO2007057548A3 (en) Method for diagnosticating hepatic diseases and for screening molecules for treating said diseases
GB201113814D0 (en) Materials and methods for determining sensitivity potential of compounds

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200780030709.4

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07809716

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2655460

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 12308542

Country of ref document: US

Ref document number: 195973

Country of ref document: IL

Ref document number: MX/A/2008/016170

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 10485/DELNP/2008

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2009516559

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 574009

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2007261405

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2007809716

Country of ref document: EP

Ref document number: 1020097001055

Country of ref document: KR

ENP Entry into the national phase

Ref document number: 2009101512

Country of ref document: RU

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2007261405

Country of ref document: AU

Date of ref document: 20070620

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: PI0712629

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20081219